SEHK:6929Medical Equipment
OrbusNeich Medical Group (SEHK:6929) Net Margin Compression Tests Bullish Growth Narrative
OrbusNeich Medical Group Holdings (SEHK:6929) opened FY 2025 with first half revenue of US$83.6 million and basic EPS of US$0.024, setting the tone for how the year is shaping up against its recent track record. The company has seen revenue move from US$78.9 million in 1H 2024 to US$85.2 million in 2H 2024 and EPS from US$0.0228 to US$0.0253 over the same period, giving investors a clear view of how the top and bottom lines have trended into the latest numbers. With net income supported by a...